A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2009
11/03/2009	US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009	US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009	US7612048 Quick water-dissolving film containing cosmetic, aromatic, pharmaceutical or food substances
11/03/2009	US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009	US7611830 Device to lavage a blood vessel
11/03/2009	US7611733 Solid Lipid Nanoparticles comprising a hydrophilic platinum complex comprising anionic ligands and ligands containing amino groups such as trans-{bis[trans(diammine)(chloro)platinum (II) ( mu -1,6-hexanediamine)]}diammineplatinum tetranitrate salt
11/03/2009	US7611731 Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture
11/03/2009	US7611730 Containing racemate of tramadol in slow-release form and (+)enantiomer of tramadol in immediate-release form; analgesic efficacy results from interplay of enantiomers by mechanism which includes non-opioid and opiod components
11/03/2009	US7611729 Dosage forms having prolonged active ingredient release
11/03/2009	US7611728 Osmotic delivery of therapeutic compounds by solubility enhancement
11/03/2009	US7611727 Pharmaceutical composition for transdermal or transmucous administration
11/03/2009	US7611724 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
11/03/2009	US7611723 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
11/03/2009	US7611722 Reduced contact of the active ingredient in solid form with the mucosa lining the gastrointestinal tract, which is particularly advantageous for delivering an ulcerative drug.
11/03/2009	US7611721 Adjuvant combination formulations
11/03/2009	US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009	US7611709 Contains one antibody and lactosucrose, glucosyl sucrose or maltosyl sucrose; powders made through spray drying or freeze drying
11/03/2009	US7611694 Scopine 2,2-diphenylpropionate-metho halides and other salts: propellant-free solution with ethanol and water and an acid; optimum nebulization; storage stability; nebulizer
11/03/2009	CA2527686C Cellulose powder
11/03/2009	CA2514224C Liquid pharmaceutical formulations of palonosetron
11/03/2009	CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
11/03/2009	CA2448035C New pharmaceutical composition
11/03/2009	CA2447924C Olopatadine formulations for topical administration
11/03/2009	CA2424579C Ultraviolet-screening patch
11/03/2009	CA2418008C Antifungal ketoconazole composition for topical use
11/03/2009	CA2415476C Matrix controlled transdermal system for stabile derivatives of ace inhibitors
11/03/2009	CA2415272C Improvements in and relating to the use of honey in dressings
11/03/2009	CA2404210C Pharmaceutical gel composition
11/03/2009	CA2402401C Compositions containing molecular iodine
11/03/2009	CA2402222C Sustained release ranolazine formulations
11/03/2009	CA2397832C Acrylic enteric coating compositions
11/03/2009	CA2383220C Controlled release pellet formulation
11/03/2009	CA2324283C Pharmaceutical composition containing a statin and aspirin
11/03/2009	CA2286378C Composition based on plant and essential oil extracts, usable in therapy, cosmetics and dietetics
11/03/2009	CA2213663C Polyalkylene block copolymers as surface modifiers for nanoparticles
11/03/2009	CA2174338C Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
10/2009
10/29/2009	WO2009132343A1 Nanoemulsions for treating onchomycosis
10/29/2009	WO2009132342A1 Nanoemulsions for treating fungal, yeast and mold infections
10/29/2009	WO2009132294A1 Polymeric artificial tear system
10/29/2009	WO2009132228A1 Chitosan-containing protective composition
10/29/2009	WO2009132227A1 Protective gel based on chitosan and oxidized polysaccharide
10/29/2009	WO2009132226A1 Thiolated chitosan gel
10/29/2009	WO2009132208A1 Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
10/29/2009	WO2009132206A1 Compositions and methods for intracellular delivery and release of cargo
10/29/2009	WO2009132153A2 Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
10/29/2009	WO2009132131A1 Amino lipid based improved lipid formulation
10/29/2009	WO2009132050A2 Auris formulations for treating otic diseases and conditions
10/29/2009	WO2009131939A2 Lipid-containing compositions and methods of use thereof
10/29/2009	WO2009131931A1 Nitric oxide-releasing compositions, devices and methods
10/29/2009	WO2009131930A1 Nanoparticle formation via rapid precipitation
10/29/2009	WO2009131927A1 Dual spray can topical delivery device
10/29/2009	WO2009131752A2 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
10/29/2009	WO2009131704A2 Nanostructures suitable for sequestering cholesterol and other molecules
10/29/2009	WO2009131473A2 Composite carrier for powdery drugs, a method of the carrier manufacturing and a plant for manufacturing the composite carrier particles
10/29/2009	WO2009131434A1 Extracellular scaffolds comprising blends of polyvinyl alcohol and carboxymethyl chitosan
10/29/2009	WO2009131216A1 Lipid membrane structure modified with oligo(alkylene glycol)
10/29/2009	WO2009130715A1 Rapidly disintegrating oral compositions of tramadol
10/29/2009	WO2009130712A2 Controlled release pharmaceutical compositions of trospium
10/29/2009	WO2009130704A1 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
10/29/2009	WO2009130515A2 Method and system for recording and promoting peripheral nerve regeneration
10/29/2009	WO2009130394A1 Gastroresistant cyclosporin formulation
10/29/2009	WO2009130332A1 Particles comprising polymers with thioester bonds
10/29/2009	WO2009130265A2 Medical device
10/29/2009	WO2009130225A2 Self-microemulsifying systems incorporated into liquid core microcapsules
10/29/2009	WO2009130204A2 Improved formulations for poorly permeable active pharmaceutical ingredients
10/29/2009	WO2009130181A2 Dry transglutaminase composition
10/29/2009	WO2009130048A1 Stabilized liquid formulation
10/29/2009	WO2009130039A1 Transdermal therapeutic system for administration of fentanyl or an analog thereof
10/29/2009	WO2009129943A1 Formulation with reduced hygroscopicity
10/29/2009	WO2009129913A1 Solid pharmaceutical preparation comprising 1-[(4-chloro-phenyl)-amide]-2-{[4-(3-oxo-morpholine-4-yl)-phenyl]-amide}-4-hydroxy-pyrrolidine-1,2-dicarboxylic acid
10/29/2009	WO2009129694A1 A new micelle formulation compriseing prostaglandin e1 entrapmented by polyglycol-derived phospholipid
10/29/2009	WO2009129627A1 Novel resveratrol compositions
10/29/2009	WO2009129592A1 Liquid formulation for deferiprone with palatable taste
10/29/2009	WO2009106831A3 Pharmaceutical composition comprising naltrexone
10/29/2009	WO2009103932A8 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain
10/29/2009	WO2009101320A3 Fine powder of polyamide from renewable materials and method for making such powder
10/29/2009	WO2009094466A3 Contact lenses for extended release of bioactive agents containing diffusion attenuators
10/29/2009	WO2009084041A3 Pharmaceutical compositions of dexibuprofen
10/29/2009	WO2009070380A3 Water-soluble carbon nanotube compositions for drug delivery and medical applications
10/29/2009	WO2009068922A3 Compositions containing capsaicinoids
10/29/2009	WO2009037264A3 Colonic delivery of antimicrobial agents
10/29/2009	WO2009013237A3 Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof
10/29/2009	WO2009005718A8 Polypeptide microparticles having sustained release characteristics, methods and uses
10/29/2009	WO2008155558A3 Microspheres
10/29/2009	WO2008148018A3 Rapidly dispersible vaginal tablet that provides a bioadhesive gel
10/29/2009	WO2008088987A9 Treatment of pain with naloxone
10/29/2009	WO2006116180A3 Hydrogel constructs using stereolithography
10/29/2009	US20090270820 System and method for use of agent in combination with subatmospheric pressure tissue treatment
10/29/2009	US20090270429 Antiviral formulation
10/29/2009	US20090270349 Physical Mode of Action Pesticide
10/29/2009	US20090270329 Methods of administering porcine b-domainless fviii
10/29/2009	US20090269414 Process of preparing microspheres for sustained release having improved dispersibility and syringeability
10/29/2009	US20090269413 Flowable collagen material for dural closure
10/29/2009	US20090269412 Pharmaceutical formulations for dry powder inhalers
10/29/2009	US20090269411 Masking the taste of powders
10/29/2009	US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009	US20090269409 Pharmaceutical compositions comprising eszopiclone
10/29/2009	US20090269407 Poly-alpha(1-4)glucopyranose-based matrices with hydrazide crosslinking
10/29/2009	US20090269406 Therapeutic uses of biocompatible biogel compositions
10/29/2009	US20090269405 Enzyme mediated delivery system

1 ... 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 ... 2991